AI-Designed Universal Vaccine Passes First Human Clinical Trial

An AI-designed universal vaccine targeting multiple coronaviruses has successfully passed its first human clinical trial, triggering immune responses in 39 healthy volunteers. This breakthrough could prevent future pandemics by providing broad protection against various coronavirus strains simultaneously. The success marks a significant milestone in leveraging artificial intelligence for medical advancements and public health security.